loadpatents
name:-0.019784927368164
name:-0.01469087600708
name:-0.0021378993988037
Routhier; Eric Patent Filings

Routhier; Eric

Patent Applications and Registrations

Patent applications and USPTO patent grants for Routhier; Eric.The latest application filed is for "high concentration anti-c5 antibody formulations".

Company Profile
1.14.18
  • Routhier; Eric - Killingworth CT
  • Routhier; Eric - Glen Mills PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
High concentration anti-C5 antibody formulations
Grant 11,365,241 - Ortiz , et al. June 21, 2
2022-06-21
High Concentration Anti-c5 Antibody Formulations
App 20200369751 - ORTIZ; Stephan ;   et al.
2020-11-26
Antigenic GM-CSF peptides and antibodies to GM-CSF
Grant 10,023,632 - Sass , et al. July 17, 2
2018-07-17
Antigenic GM-CSF Peptides and Antibodies to GM-CSF
App 20160333089 - Sass; Philip M. ;   et al.
2016-11-17
Antigenic GM-CSF peptides and antibodies to GM-CSF
Grant 9,422,367 - Sass , et al. August 23, 2
2016-08-23
Anti-mesothelin antibodies
Grant 9,115,197 - Ebel , et al. August 25, 2
2015-08-25
Anti-Mesothelin Antibodies
App 20140127237 - Ebel; Wolfgang ;   et al.
2014-05-08
Antigenic GM-CSF Peptides and Antibodies to GM-CSF
App 20140086928 - Sass; Philip M. ;   et al.
2014-03-27
Anti-mesothelin antibodies
Grant 8,658,173 - Ebel , et al. February 25, 2
2014-02-25
Antigenic GM-CSF peptides and antibodies to GM-CSF
Grant 8,623,364 - Sass , et al. January 7, 2
2014-01-07
Anti-Mesothelin Antibodies
App 20130177571 - Ebel; Wolfgang ;   et al.
2013-07-11
Anti-mesothelin antibodies
Grant 8,481,703 - Ebel , et al. July 9, 2
2013-07-09
Antigenic GM-CSF Peptides and Antibodies to GM-CSF
App 20130058945 - Sass; Philip M. ;   et al.
2013-03-07
Antigenic GM-CSF peptides and antibodies to GM-CSF
Grant 8,318,168 - Sass , et al. November 27, 2
2012-11-27
Anti-Mesothelin Antibodies
App 20120237509 - Ebel; Wolfgang ;   et al.
2012-09-20
Anti-folate Receptor Alpha Antibody Glycoforms
App 20120164137 - Sass; Philip M. ;   et al.
2012-06-28
Anti-mesothelin antibodies
Grant 8,206,710 - Ebel , et al. June 26, 2
2012-06-26
Antigenic GM-CSF Peptides And Antibodies To GM-CSF
App 20100272730 - Sass; Philip M. ;   et al.
2010-10-28
Antibodies to GM-CSF
Grant 7,741,450 - Sass , et al. June 22, 2
2010-06-22
Anti-Mesothelin Antibodies
App 20100028336 - Ebel; Wolfgang ;   et al.
2010-02-04
Anti-gd2 Antibodies And Methods And Uses Related Thereto
App 20100008851 - Nicolaides; Nicholas C. ;   et al.
2010-01-14
Anti-mesothelin antibodies
Grant 7,592,426 - Ebel , et al. September 22, 2
2009-09-22
Anti-Mesothelin Antibodies
App 20090202559 - Ebel; Wolfgang ;   et al.
2009-08-13
Antigenic GM-CSF peptides and antibodies to GM-CSF
App 20080292641 - Sass; Philip M. ;   et al.
2008-11-27
Antibodies That Specifically Bind PMS2
App 20080124744 - Grasso; Luigi ;   et al.
2008-05-29
Antibodies that specifically bind PMS2
Grant 7,332,584 - Grasso , et al. February 19, 2
2008-02-19
Anti-mesothelin antibodies
App 20060204506 - Ebel; Wolfgang ;   et al.
2006-09-14
Antibodies that specifically bind PMS2
App 20060009621 - Grasso; Luigi ;   et al.
2006-01-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed